rs2736627
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000314.8(PTEN):c.1026+219C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.911 in 521,718 control chromosomes in the GnomAD database, including 216,918 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.92 ( 64833 hom., cov: 31)
Exomes 𝑓: 0.91 ( 152085 hom. )
Consequence
PTEN
NM_000314.8 intron
NM_000314.8 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.893
Publications
11 publications found
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-87961337-C-T is Benign according to our data. Variant chr10-87961337-C-T is described in ClinVar as Benign. ClinVar VariationId is 1245322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | c.1026+219C>T | intron_variant | Intron 8 of 8 | ENST00000371953.8 | NP_000305.3 | ||
| PTEN | NM_001304717.5 | c.1545+219C>T | intron_variant | Intron 9 of 9 | NP_001291646.4 | |||
| PTEN | NM_001304718.2 | c.435+219C>T | intron_variant | Intron 8 of 8 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.921 AC: 140132AN: 152104Hom.: 64767 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
140132
AN:
152104
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.906 AC: 334811AN: 369496Hom.: 152085 Cov.: 4 AF XY: 0.908 AC XY: 177769AN XY: 195732 show subpopulations
GnomAD4 exome
AF:
AC:
334811
AN:
369496
Hom.:
Cov.:
4
AF XY:
AC XY:
177769
AN XY:
195732
show subpopulations
African (AFR)
AF:
AC:
10607
AN:
10842
American (AMR)
AF:
AC:
14265
AN:
15606
Ashkenazi Jewish (ASJ)
AF:
AC:
9415
AN:
11224
East Asian (EAS)
AF:
AC:
24713
AN:
24716
South Asian (SAS)
AF:
AC:
38246
AN:
39502
European-Finnish (FIN)
AF:
AC:
18779
AN:
20340
Middle Eastern (MID)
AF:
AC:
1388
AN:
1598
European-Non Finnish (NFE)
AF:
AC:
198227
AN:
224386
Other (OTH)
AF:
AC:
19171
AN:
21282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1449
2898
4348
5797
7246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
950
1900
2850
3800
4750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.921 AC: 140256AN: 152222Hom.: 64833 Cov.: 31 AF XY: 0.924 AC XY: 68755AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
140256
AN:
152222
Hom.:
Cov.:
31
AF XY:
AC XY:
68755
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
40792
AN:
41546
American (AMR)
AF:
AC:
13860
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
2906
AN:
3472
East Asian (EAS)
AF:
AC:
5180
AN:
5182
South Asian (SAS)
AF:
AC:
4689
AN:
4826
European-Finnish (FIN)
AF:
AC:
9851
AN:
10594
Middle Eastern (MID)
AF:
AC:
259
AN:
292
European-Non Finnish (NFE)
AF:
AC:
59936
AN:
68000
Other (OTH)
AF:
AC:
1908
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
567
1135
1702
2270
2837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3418
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.